NYSE:ALL - Allstate Stock Price, Forecast & News

Allstate trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALL."

Allstate declared a quarterly dividend on Friday, November 15th. Stockholders of record on Friday, November 29th will be paid a dividend of $0.50 per share on Thursday, January 2nd. This represents a $2.00 annualized dividend and a dividend yield of 1.69%. The ex-dividend date of this dividend is Wednesday, November 27th. View Allstate's Dividend History.

Allstate Corp (NYSE:ALL) announced its quarterly earnings data on Tuesday, October, 29th. The insurance provider reported $2.84 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $2.52 by $0.32. The insurance provider had revenue of $10.87 billion for the quarter, compared to analyst estimates of $9.07 billion. Allstate had a net margin of 6.57% and a return on equity of 13.83%. During the same quarter last year, the company earned $1.93 EPS. View Allstate's Earnings History.

Allstate is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Allstate.

Allstate will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

12 equities research analysts have issued 1 year price targets for Allstate's shares. Their forecasts range from $94.00 to $135.00. On average, they anticipate Allstate's share price to reach $114.64 in the next year. This suggests that the stock has a possible downside of 3.0%. View Analyst Price Targets for Allstate.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allstate in the last year. There are currently 1 sell rating, 6 hold ratings, 4 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allstate.

News headlines about ALL stock have trended negative on Friday, according to InfoTrie. The research group scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Allstate earned a media sentiment score of -2.6 on InfoTrie's scale. They also gave news coverage about the insurance provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Allstate.

Allstate saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 3,910,000 shares, an increase of 15.0% from the December 15th total of 3,400,000 shares. Based on an average daily trading volume, of 1,560,000 shares, the days-to-cover ratio is presently 2.5 days. Currently, 1.2% of the shares of the company are short sold. View Allstate's Current Options Chain.

Some companies that are related to Allstate include Berkshire Hathaway (BRK.B), Progressive (PGR), Travelers Companies (TRV), Arch Capital Group (ACGL), Cincinnati Financial (CINF), Markel (MKL), Fidelity National Financial (FNF), W. R. Berkley (WRB), Cna Financial (CNA), Erie Indemnity (ERIE), Old Republic International (ORI), First American Financial (FAF), Hanover Insurance Group (THG), Axis Capital (AXS) and Assured Guaranty (AGO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Allstate investors own include Chipotle Mexican Grill (CMG), Endologix (ELGX), CA (CA), Honeywell International (HON), Micron Technology (MU), BlackRock (BLK), Accenture (ACN), AT&T (T), Cisco Systems (CSCO) and Allergan (AGN).

Allstate's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Atalanta Sosnoff Capital LLC (0.21%), PGGM Investments (0.18%), Candriam Luxembourg S.C.A. (0.10%), Gateway Investment Advisers LLC (0.08%), Zurcher Kantonalbank Zurich Cantonalbank (0.08%) and Nisa Investment Advisors LLC (0.05%). Company insiders that own Allstate stock include Croker Trevor, Glenn T Shapiro, Harriet K Harty, Jesse E Merten, Judith A Sprieser, Mary Jane Fortin, Steven E Shebik and Susan L Lees. View Institutional Ownership Trends for Allstate.

ALL stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., PGGM Investments, Assenagon Asset Management S.A., Mckinley Capital Management LLC Delaware, Gateway Investment Advisers LLC, Dalton Greiner Hartman Maher & Co., Nisa Investment Advisors LLC and OLD National Bancorp IN. Company insiders that have sold Allstate company stock in the last year include Glenn T Shapiro, Jesse E Merten, Judith A Sprieser, Mary Jane Fortin, Steven E Shebik and Susan L Lees. View Insider Buying and Selling for Allstate.

ALL stock was bought by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., DNB Asset Management AS, Bowling Portfolio Management LLC, Zurcher Kantonalbank Zurich Cantonalbank, Loveless Wealth Management LLC, Janney Montgomery Scott LLC, J.W. Cole Advisors Inc. and Allworth Financial LP. View Insider Buying and Selling for Allstate.

Shares of ALL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALL stock can currently be purchased for approximately $118.15.

Allstate has a market capitalization of $38.28 billion and generates $39.82 billion in revenue each year. The insurance provider earns $2.25 billion in net income (profit) each year or $8.07 on an earnings per share basis. Allstate employs 45,700 workers across the globe.View Additional Information About Allstate.

The official website for Allstate is http://www.allstate.com/.

Allstate's mailing address is 2775 SANDERS ROAD, NORTHBROOK IL, 60062. The insurance provider can be reached via phone at 847-402-5000 or via email at [email protected]